array(3) { ["company_details"]=> array(13) { ["name"]=> string(24) "Idexx Laboratories, Inc." ["slug"]=> string(31) "52dfe-us-idexx-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62" ["description"]=> string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries. Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities." ["address_street"]=> string(10) "1 Idexx Dr" ["address_place"]=> string(9) "Westbrook" ["address_region"]=> string(5) "Maine" ["founding_date"]=> string(10) "1983-02-28" ["website_domain"]=> string(9) "idexx.com" ["website_url"]=> string(21) "https://www.idexx.com" ["industry_codes"]=> array(4) { [0]=> string(43) "General Livestock, Except Dairy and Poultry" [1]=> string(33) "Veterinary Services for Livestock" [2]=> string(27) "Pharmaceutical Preparations" [3]=> string(42) "In Vitro and In Vivo Diagnostic Substances" } ["employee_count"]=> int(710) ["article_count"]=> int(634) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(168) "Immunopathological investigation and genetic evolution of Avian leukosis virus Subgroup-J associated with myelocytomatosis in broiler flocks in Egypt - Virology Journal" ["snippet_en"]=> string(296) "Background Avian leukosis virus Subgroup-J (ALV-J) is a rapidly oncogenic evolving retrovirus infecting a variety of avian species; causing severe economic losses to the local poultry industry. Methods To investigate ALV-J, a total of 117 blood samples and 57 tissue specimens of different organs" ["url"]=> string(71) "https://virologyj.biomedcentral.com/articles/10.1186/s12985-024-02329-7" ["image_url"]=> string(78) "https://images.businessradar.com/articles/22af36e8-b4eb-4e38-ad9a-9d7eea02aef8" ["source"]=> string(17) "biomedcentral.com" ["publication_date"]=> string(10) "2024-04-10" ["categories"]=> array(1) { [0]=> string(25) "Business Model Resilience" } } [1]=> array(7) { ["title_en"]=> string(82) "IDEXX Colilert®-18 approved for the detection of E. coli in water reuse in France" ["snippet_en"]=> string(183) "Two new national decrees relating to the use of treated wastewater approve the IDEXX Colilert-18® microbiological test, for the detection of coliforms and Escherichia coli (E. coli)." ["url"]=> string(130) "https://www.revue-ein.com/actualite/idexx-colilert-18-approuve-pour-la-detection-d-e-coli-dans-la-reutilisation-de-l-eau-en-france" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ec8eea93-8982-4ce2-a382-c9544c27f9cd" ["source"]=> string(13) "revue-ein.com" ["publication_date"]=> string(10) "2024-04-09" ["categories"]=> array(0) { } } [2]=> array(7) { ["title_en"]=> string(84) "Will Avid Bioservices (USA Stocks:CDMO) investors shift to IDEXX (USA Stocks:IDXX)?" ["snippet_en"]=> string(295) "Despite Avid Bioservices' (USA Stocks: CDMO) current market capitalization of $400.9M and Wall Street's target price of $12.25, the company's financial health raises concerns due to its EBITDA showing a loss of $501K and a negative operating margin of -0.44. Given these factors, investors might" ["url"]=> string(131) "https://www.macroaxis.com/invest/story/CDMO/31258361/Will-Avid-Bioservices-USA-Stocks-CDMO-investors-shift-to-IDEXX-USA-Stocks-IDXX" ["image_url"]=> string(78) "https://images.businessradar.com/articles/72c924fb-8278-46f6-8a41-59e4046dc4fa" ["source"]=> string(13) "macroaxis.com" ["publication_date"]=> string(10) "2024-04-07" ["categories"]=> array(3) { [0]=> string(9) "Investors" [1]=> string(12) "Stock Market" [2]=> string(15) "Market Movement" } } [3]=> array(7) { ["title_en"]=> string(66) "IDEXX Laboratories to Release 2024 First Quarter Financial Results" ["snippet_en"]=> string(233) "WESTBROOK, Maine, April 04, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens." ["url"]=> string(90) "https://es-us.finanzas.yahoo.com/news/idexx-laboratories-release-2024-first-203000755.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/05f95f58-f430-4b50-a78f-c08f08e16130" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2024-04-04" ["categories"]=> array(3) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" [2]=> string(14) "Product Launch" } } [4]=> array(7) { ["title_en"]=> string(83) "Elanco expands board of directors with two new directors According to Investing.com" ["snippet_en"]=> string(60) "Elanco expands its board of directors with two new directors" ["url"]=> string(109) "https://vn.investing.com/news/company-news/elanco-mo-rong-hoi-dong-quan-tri-voi-hai-giam-doc-moi-93CH-2108021" ["image_url"]=> NULL ["source"]=> string(13) "investing.com" ["publication_date"]=> string(10) "2024-04-01" ["categories"]=> array(6) { [0]=> string(13) "Collaboration" [1]=> string(14) "Product Launch" [2]=> string(12) "Board Change" [3]=> string(18) "Board Compensation" [4]=> string(21) "Shareholders Feedback" [5]=> string(18) "Expansion & Growth" } } [5]=> array(7) { ["title_en"]=> string(63) "VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript" ["snippet_en"]=> string(290) "VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript March 26, 2024 VolitionRx Limited isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and thank you for standing by." ["url"]=> string(77) "https://finance.yahoo.com/news/volitionrx-limited-amex-vnrx-q4-163122822.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/452ebebf-b2b3-4060-a1e8-c8e17f81a58e" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2024-03-27" ["categories"]=> array(3) { [0]=> string(13) "Collaboration" [1]=> string(15) "Deals & Tenders" [2]=> string(24) "Quarterly/Annual Figures" } } [6]=> array(7) { ["title_en"]=> string(112) "Veterinary Radiology Software Market Analysis and Revenue Prediction | VetZ GmbH, IDEXX, Paxeramed Corp - Amoré" ["snippet_en"]=> string(112) "Veterinary Radiology Software Market Analysis and Revenue Prediction | VetZ GmbH, IDEXX, Paxeramed Corp - Amoré" ["url"]=> string(129) "http://amore.ng/worldwide/23/veterinary-radiology-software-market-analysis-and-revenue-prediction-vetz-gmbh-idexx-paxeramed-corp/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c1652210-6a2e-44fe-a1b7-3505e4cb3ed7" ["source"]=> string(8) "amore.ng" ["publication_date"]=> string(10) "2024-03-21" ["categories"]=> array(1) { [0]=> string(31) "Financial Update/Profit Warning" } } [7]=> array(7) { ["title_en"]=> string(76) "IDEXX Laboratories shares cannot maintain previous day's level (€490.9692)" ["snippet_en"]=> string(131) "The shares of IDEXX Laboratories were trading slightly lighter on Thursday. Most recently, investors paid $534.42 for the security." ["url"]=> string(95) "https://www.ariva.de/news/aktie-von-idexx-laboratories-kann-vortagsniveau-nicht-halten-11177664" ["image_url"]=> string(78) "https://images.businessradar.com/articles/7cf0aa94-7659-4b52-bf2f-749377a604e0" ["source"]=> string(8) "ariva.de" ["publication_date"]=> string(10) "2024-03-14" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(24) "Stock Research & Ratings" } } [8]=> array(7) { ["title_en"]=> string(89) "IDEXX carries out the Ask the Kidneys campaign? for real health awareness in Yellow March" ["snippet_en"]=> string(156) "The initiative involves weekly interactive talk shows with specialists in cardiology, infectious diseases, gastroenterology and endocrinology. Action has ap" ["url"]=> string(125) "https://portalrbn.com.br/idexx-realiza-a-campanha-pergunte-aos-rins-para-conscientizacao-sobre-a-saude-real-no-marco-amarelo/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/7ed7cff2-4925-4602-ba6b-f640cc4b3d7b" ["source"]=> string(16) "portalrbn.com.br" ["publication_date"]=> string(10) "2024-03-07" ["categories"]=> array(0) { } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(116) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(64) } [2]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(42) } [3]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(41) } [4]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(40) } [5]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(23) } [6]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(22) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(22) } [8]=> array(2) { ["name"]=> string(12) "Restatements" ["count"]=> int(21) } [9]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(18) } [11]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(16) } [12]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(12) } [14]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(8) } [16]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(8) } [18]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(8) } [19]=> array(2) { ["name"]=> string(9) "Investors" ["count"]=> int(8) } [20]=> array(2) { ["name"]=> string(31) "Water and Wastewater Management" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [26]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(5) } } } 52dfe-us-idexx-laboratories-inc